RESUMEN
Pituitary adenylate cyclase activating polypeptide (PACAP) is a pleiotropic and multifunctional neuropeptide having important roles in various physiological processes. Recent trends in PACAP research point to the clinical introduction of PACAP or its analogs/fragments possibly in the near future. Recently, we have shown the presence of PACAP in human plasma, milk, placenta, and follicular fluid samples. However, relatively few data are available on PACAP in human tissues from patients with different disorders. The aim of the present study was to determine, by radioimmunoassay, the tissue level of PACAP38-like immunoreactivity (LI) and PACAP27-LI in different primary non-small cell lung cancer, colon tumor samples, and in cardiac muscle samples from patients suffering from ischemic heart disease and valvular disorders. We also labeled the PAC1 receptors in human cardiac cells. All samples showed significantly higher PACAP38-LI compared with PACAP27-LI. We found significantly lower levels of PACAP38-LI and PACAP27-LI in tumoral and peripheral samples compared with normal healthy tissue in both lung and colon cancers. Further investigations are necessary to describe the exact function of PACAP in oncogenesis. We showed that PACAP38-LI and PACAP27-LI are significantly higher in ischemic heart diseases compared with valvular abnormalities, suggesting that PACAP might play a role in ischemic heart disorders.
Asunto(s)
Adenocarcinoma/química , Carcinoma de Pulmón de Células no Pequeñas/química , Neoplasias del Colon/química , Enfermedades de las Válvulas Cardíacas/metabolismo , Neoplasias Pulmonares/química , Isquemia Miocárdica/metabolismo , Miocitos Cardíacos/química , Proteínas de Neoplasias/análisis , Polipéptido Hipofisario Activador de la Adenilato-Ciclasa/análisis , Adenocarcinoma/patología , Carcinoma de Pulmón de Células no Pequeñas/patología , Colon/química , Neoplasias del Colon/patología , Enfermedades de las Válvulas Cardíacas/patología , Humanos , Pulmón/química , Neoplasias Pulmonares/patología , Isquemia Miocárdica/patología , Miocardio/química , Polipéptido Hipofisario Activador de la Adenilato-Ciclasa/fisiología , Isoformas de Proteínas/análisis , Radioinmunoensayo , Receptores del Polipéptido Activador de la Adenilato-Ciclasa Hipofisaria/análisisRESUMEN
Gluten sensitive enteropathy has various manifestations, of which the two major forms are classical coeliac disease (cCD) and dermatitis herpetiformis (DH). In cCD predominantly the small intestine is affected, whereas in DH also the skin is affected showing typical rash and IgA deposits. The symptoms in both forms are dependent on gluten intake. The factors diversifying these two clinical outcomes are unknown. In the present report we evaluated the role of the major genetic susceptibility locus, HLA DQ, in 25 families, in which both forms of the disease, cCD and DH, occurred in siblings. By using the family-based approach it can be assumed that within each family variation in environmental factors is substantially lower than in the standard case-control setting, and also the problems related to population stratification can be avoided. Results from the Finnish family material with 25 discordant and 85 concordant sib pairs, and from additional case-control material comprising 71 unrelated Hungarian DH and 68 cCD patients, together indicated that the HLA DQ locus did not differ between the two major outcomes of gluten sensitive enteropathy. The non-HLA DR;DQ factors are critical for the different clinical manifestations of gluten sensitivity.